KALA
KALA
NASDAQ · Biotechnology

Kala Bio Inc

$0.95
+0.02 (+2.33%)
As of Aug 14, 10:22 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,083.5% upside
Low Target $8.32
Average Target $11.19
High Target $14.48
Current Price $0.95
Current
$0.95
Target
$11.19
$8.32 $11.19 avg $14.48
Scenario Analysis
Bear Case
$8.32
780.0%
Low target
Base Case
$11.19
+1,083.5%
Avg target
Bull Case
$14.48
+1,431.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$11.19
-98.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%